These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25592443)

  • 1. Low-dose endothelial monocyte-activating polypeptide-II increases permeability of blood-tumor barrier via a PKC-ζ/PP2A-dependent signaling mechanism.
    Li Z; Liu YH; Liu XB; Xue YX; Wang P; Liu LB
    Exp Cell Res; 2015 Feb; 331(2):257-66. PubMed ID: 25592443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of Serine/Threonine Phosphatases in Low-Dose Endothelial Monocyte-Activating Polypeptide-II-Induced Opening of Blood-Tumor Barrier.
    Li Z; Liu XB; Liu YH; Xue YX; Wang P; Liu LB; Liu J; Yao YL; Ma J
    J Mol Neurosci; 2015 Sep; 57(1):11-20. PubMed ID: 26087743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Increases Blood-Tumor Barrier Permeability by Activating the RhoA/ROCK/PI3K Signaling Pathway.
    Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL
    J Mol Neurosci; 2016 Jun; 59(2):193-202. PubMed ID: 26521255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal mechanisms underlying low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
    Li Z; Liu YH; Xue YX; Liu LB; Wang P
    J Mol Neurosci; 2012 Sep; 48(1):291-301. PubMed ID: 22531886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Induces Blood-Tumor Barrier Opening Via the cAMP/PKA/Rac1 Pathway.
    Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL
    J Mol Neurosci; 2016 Feb; 58(2):153-61. PubMed ID: 26358039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cAMP-dependent protein kinase A activity in low-dose endothelial monocyte-activating polypeptide-II-induced opening of blood-tumor barrier.
    Li Z; Liu XB; Liu YH; Xue YX; Wang P; Liu LB
    J Mol Neurosci; 2015 May; 56(1):60-9. PubMed ID: 25416651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of RhoA/ROCK signaling in endothelial-monocyte-activating polypeptide II opening of the blood-tumor barrier: role of RhoA/ROCK signaling in EMAP II opening of the BTB.
    Xie H; Xue YX; Liu LB; Liu YH; Wang P
    J Mol Neurosci; 2012 Mar; 46(3):666-76. PubMed ID: 21647708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of ATP synthase alpha subunit in low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
    Li Z; Liu YH; Xue YX; Xie H; Liu LB
    J Neurol Sci; 2011 Jan; 300(1-2):52-8. PubMed ID: 21035144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive effect of low-frequency ultrasound and endothelial monocyte-activating polypeptide II on blood-tumor barrier in rats with brain glioma.
    Zhang Z; Xue Y; Liu Y; Shang X
    Neurosci Lett; 2010 Aug; 481(1):21-5. PubMed ID: 20600613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial-monocyte-activating polypeptide II increases blood-tumor barrier permeability by down-regulating the expression levels of tight junction associated proteins.
    Xie H; Xue YX; Liu LB; Liu YH
    Brain Res; 2010 Mar; 1319():13-20. PubMed ID: 20083091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functions for the cAMP/Epac/Rap1 Signaling Pathway in Low-Dose Endothelial Monocyte-Activating Polypeptide-II-Induced Opening of Blood-Tumor Barrier.
    Li Z; Liu XB; Liu YH; Xue YX; Wang P; Liu LB; Yao YL; Ma J
    J Mol Neurosci; 2015 Sep; 57(1):1-10. PubMed ID: 26044663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms for endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
    Li Z; Liu YH; Xue YX; Liu LB; Xie H
    J Mol Neurosci; 2012 Jun; 47(2):408-17. PubMed ID: 21969114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose endothelial monocyte-activating polypeptide-ii increases permeability of blood-tumor barrier by caveolae-mediated transcellular pathway.
    Li Z; Liu YH; Xue YX; Liu LB; Wang P
    J Mol Neurosci; 2014 Mar; 52(3):313-22. PubMed ID: 24526454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of miR-330-3p/PKC-α Signaling Pathway in Low-Dose Endothelial-Monocyte Activating Polypeptide-II Increasing the Permeability of Blood-Tumor Barrier.
    Liu J; Liu L; Chao S; Liu Y; Liu X; Zheng J; Chen J; Gong W; Teng H; Li Z; Wang P; Xue Y
    Front Cell Neurosci; 2017; 11():358. PubMed ID: 29311822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin-induced phosphorylation of the regulatory light chain of myosin II in cultured bovine corneal endothelial cells.
    Satpathy M; Gallagher P; Lizotte-Waniewski M; Srinivas SP
    Exp Eye Res; 2004 Oct; 79(4):477-86. PubMed ID: 15381032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PKC and RhoA signals cross-talk in Escherichia coli endotoxin induced alterations in brain endothelial permeability.
    He F; Yin F; Omran A; Yang LF; Xiang QL; Peng J
    Biochem Biophys Res Commun; 2012 Aug; 425(2):182-8. PubMed ID: 22846579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulatory phosphorylation of cAMP-specific PDE4D5 by contractile agonists is mediated by PKC-dependent inactivation of protein phosphatase 2A.
    Murthy KS; Sriwai W
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G327-35. PubMed ID: 18006600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minoxidil sulfate induced the increase in blood-brain tumor barrier permeability through ROS/RhoA/PI3K/PKB signaling pathway.
    Gu YT; Xue YX; Wang YF; Wang JH; Chen X; ShangGuan QR; Lian Y; Zhong L; Meng YN
    Neuropharmacology; 2013 Dec; 75():407-15. PubMed ID: 23973310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-429 Regulated by Endothelial Monocyte Activating Polypeptide-II (EMAP-II) Influences Blood-Tumor Barrier Permeability by Inhibiting the Expressions of ZO-1, Occludin and Claudin-5.
    Chen L; Xue Y; Zheng J; Liu X; Liu J; Chen J; Li Z; Xi Z; Teng H; Wang P; Liu L; Liu Y
    Front Mol Neurosci; 2018; 11():35. PubMed ID: 29467620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
    Liu LB; Xue YX; Liu YH; Wang YB
    J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.